Workflow
高端微波射频仪器
icon
Search documents
普源精电: 国泰海通证券股份有限公司关于普源精电科技股份有限公司使用自有资金、信用证等方式支付募投项目部分款项后续以募集资金等额置换的核查意见
Zheng Quan Zhi Xing· 2025-06-04 09:18
(二)以简易程序向特定对象发行股票 国泰海通证券股份有限公司关于普源精电科技股份有限公司使 用自有资金、信用证等方式支付募投项目部分款项后续以募集 资金等额置换的核查意见 国泰海通证券股份有限公司(以下简称"国泰海通"或"保荐机构"或"独 立财务顾问")作为普源精电科技股份有限公司(以下简称"公司"、 "普源精电" 或"发行人")首次公开发行股票并在科创板上市、2023 年以简易程序向特定对 象发行股票的保荐机构及持续督导机构、发行股份购买资产并募集配套资金的独 立财务顾问,根据《上市公司募集资金监管规则》《上海证券交易所科创板股票 上市规则》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》等有 关法律法规和规范性文件的要求,对普源精电使用自有资金、信用证等方式支付 募投项目所需资金并以募集资金等额置换的事项进行了核查,核查情况及核查意 见如下: 一、募集资金基本情况 (一)首次公开发行股票 根据中国证券监督管理委员会于 2022 年 2 月 24 日出具的《关于同意普源精 (证监许可〔2022〕399 号), 电科技股份有限公司首次公开发行股票注册的批复》 同意公司首次公开发行股票的注册申请,并 ...
普源精电: 国泰海通证券股份有限公司关于普源精电科技股份有限公司使用部分超募资金永久补充流动资金的核查意见
Zheng Quan Zhi Xing· 2025-06-04 09:18
Summary of Key Points Core Viewpoint - The company intends to use part of the excess raised funds to permanently supplement its working capital, which is deemed beneficial for improving fund utilization efficiency and reducing financial costs [1][5][9]. Group 1: Fundraising Overview - The company successfully completed its initial public offering (IPO) on April 1, 2022, issuing 30,327,389 shares at a price of RMB 60.88 per share, raising a total of RMB 184,633.14 million [1][7]. - After deducting issuance costs of RMB 18,020.43 million, the net amount raised was RMB 166,612.72 million, with excess funds amounting to RMB 91,612.72 million [1][3][7]. Group 2: Fund Utilization Plan - The planned allocation of the raised funds includes various projects, with a total investment of RMB 76,763.12 million, of which RMB 5,000 million is designated for working capital [3][5]. - The company has previously used RMB 27,400 million of excess funds for working capital, representing 29.91% of the total excess funds [3][6]. Group 3: Approval and Compliance - The board of directors and the supervisory board have approved the use of RMB 27,400 million of excess funds for working capital, which will be submitted for shareholder approval [6][8]. - The company commits that the total amount used for working capital will not exceed 30% of the excess funds within any 12-month period, ensuring compliance with regulatory requirements [6][9].